Champions Biotechnology Inc. (CSBR.OB) Obtains Exclusive License for Cancer Treatment in Collaboration with Yale and Southern Research Institute
Champions Biotechnology Inc. focuses on oncology drug developments and preclinical platforms and data to enhance and accelerate the value of those drugs. The company today announced an exclusive licensing agreement with Yale University and Southern Research Institute for the development of Bithionol for cancer treatment. According to scientists from Yale and Southern Research, Bithionol, which is available for parasitic infections, shows activity against solid cancerous tumors and may be effective in treating melanoma, prostate, breast, lung and other cancers. Per the agreement, Yale and Southern Research will receive an upfront payment, as well as milestone payments and royalties; Champions has…